Amagma Therapeutics
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Drug Discovery Technologies
- Large Molecule
- Pharmaceuticals
See more in Biomedtracker
Latest on Amagma Therapeutics
Scrip
• By Mandy Jackson
October ended and November began with the announcement of three new venture capital and equity funds with more than $1.3bn for health care, life science and biopharmaceutical investments. Revelation P
Scrip
• By Jung Won Shin, Vibha Ravi, Dexter Jie Yan, Ian Haydock, and Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Orange Grove, SV Investment Align With
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Amgen, Plexium Team Up Against Challeng